Search This Blog

Wednesday, October 30, 2019

ACADIA Pharma EPS beats by $0.11, beats on revenue

ACADIA Pharma (NASDAQ:ACAD): Q3 GAAP EPS of -$0.29 beats by $0.11.
Revenue of $94.6M (+62.3% Y/Y) beats by $6.11M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)